ENDRA Life Sciences
Business Services · Michigan, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3600 Green Ct Ste 350, Ann Arbor, Michig...Phone Number
(734) 335-0468Website
www.endrainc.comRevenue
-Stock Symbol
NDRAIndustry
About ENDRA Life Sciences
ENDRA Life Sciences Org Chart
Is ENDRA Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once ENDRA Life Sciences has new funding data
Check if ENDRA Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on ENDRA Life Sciences recently announced quarterly report
ENDRA Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if ENDRA Life Sciences is spiking on competitors!
Product Launch: Get notified when ENDRA Life Sciences launches new products
Website visits: Recent activity has been detected on your website
Click to see if ENDRA Life Sciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at ENDRA Life Sciences
Recommended Actions
Reach out to Masked Content who joined ENDRA Life Sciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to ENDRA Life Sciences
Compare insights from companies similar to ENDRA Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ENDRA Life Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ENDRA Life Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ENDRA Life Sciences.
ENDRA Life Sciences financials insights
Gather financial insights about ENDRA Life Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Stock Offering
$8.4M
Debt
$150K
Private Equity
$4.9M
Private Equity
$14.4M
ENDRA Life Sciences Tech Stack
A closer look at the technologies used by ENDRA Life Sciences
Most Recent Scoops
ENDRA Life Sciences News & Media
ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today provided a business update and reported financial results for the three months ended March 31, 2025. Business Update Incorporating Liver Diagnostics into the Management of Metabolic Disease ENDRA recently announced a strategic pivot to position the company to play an integral role in the treatment of metabolic disease. With a sharpened mission to transformENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today announced a new strategic direction to develop and deploy its TAEUS system as a biomarker solution for the early detection and management of metabolic diseases in patients being treated with glucagon-like peptide-1 (GLP-1) drugs and other metabolic dysfunction-associated steatohepatitis (MASH) therapies. ENDRA’s management has thoroughly evaluated the CompENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the fourth quarter and full-year ended December 31, 2024, and provided a business update. Business Update ENDRA made significant progress against many of the new initiatives discussed during the Company’s August 22, 2024, conference call to advance its TAEUS Liver device along the development and regulatory process. In additiENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and nine months ended September 30, 2024 and provided a business update. Highlights from the third quarter and recent weeks include: Developed data analysis features for TAEUS platform by introducing new models rooted in artificial intelligence (AI), machine learning (ML) and deep learning (DL). As part of its conti
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ENDRA Life Sciences
Endra Life Sciences is focused on early detection of liver disease. Endra Life Sciences was founded in 2009 and is headquartered in Ann Arbor, Michigan.... Read More